BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31672265)

  • 1. Large in-frame 5' deletions in DMD associated with mild Duchenne muscular dystrophy: Two case reports and a review of the literature.
    Gibbs EM; Barthélémy F; Douine ED; Hardiman NC; Shieh PB; Khanlou N; Crosbie RH; Nelson SF; Miceli MC
    Neuromuscul Disord; 2019 Nov; 29(11):863-873. PubMed ID: 31672265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to exon 44 or 45 skipping.
    Anthony K; Arechavala-Gomeza V; Ricotti V; Torelli S; Feng L; Janghra N; Tasca G; Guglieri M; Barresi R; Armaroli A; Ferlini A; Bushby K; Straub V; Ricci E; Sewry C; Morgan J; Muntoni F
    JAMA Neurol; 2014 Jan; 71(1):32-40. PubMed ID: 24217213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials.
    Anthony K; Cirak S; Torelli S; Tasca G; Feng L; Arechavala-Gomeza V; Armaroli A; Guglieri M; Straathof CS; Verschuuren JJ; Aartsma-Rus A; Helderman-van den Enden P; Bushby K; Straub V; Sewry C; Ferlini A; Ricci E; Morgan JE; Muntoni F
    Brain; 2011 Dec; 134(Pt 12):3547-59. PubMed ID: 22102647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies.
    Toh ZY; Thandar Aung-Htut M; Pinniger G; Adams AM; Krishnaswarmy S; Wong BL; Fletcher S; Wilton SD
    PLoS One; 2016; 11(1):e0145620. PubMed ID: 26745801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DMD genotype correlations from the Duchenne Registry: Endogenous exon skipping is a factor in prolonged ambulation for individuals with a defined mutation subtype.
    Wang RT; Barthelemy F; Martin AS; Douine ED; Eskin A; Lucas A; Lavigne J; Peay H; Khanlou N; Sweeney L; Cantor RM; Miceli MC; Nelson SF
    Hum Mutat; 2018 Sep; 39(9):1193-1202. PubMed ID: 29907980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duchenne and Becker muscular dystrophy: a molecular and immunohistochemical approach.
    Freund AA; Scola RH; Arndt RC; Lorenzoni PJ; Kay CK; Werneck LC
    Arq Neuropsiquiatr; 2007 Mar; 65(1):73-6. PubMed ID: 17420831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.
    Lee JJA; Saito T; Duddy W; Takeda S; Yokota T
    Methods Mol Biol; 2018; 1828():141-150. PubMed ID: 30171539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-level dystrophin expression attenuating the dystrophinopathy phenotype.
    Waldrop MA; Gumienny F; El Husayni S; Frank DE; Weiss RB; Flanigan KM
    Neuromuscul Disord; 2018 Feb; 28(2):116-121. PubMed ID: 29305136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The X-linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45-47.
    Heier CR; McCormack NM; Tully CB; Novak JS; Newell-Stamper BL; Russell AJ; Fiorillo AA
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):940-954. PubMed ID: 36628607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duchenne muscular dystrophy in a female with compound heterozygous contiguous exon deletions.
    Takeshita E; Minami N; Minami K; Suzuki M; Awashima T; Ishiyama A; Komaki H; Nishino I; Sasaki M
    Neuromuscul Disord; 2017 Jun; 27(6):569-573. PubMed ID: 28434908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.
    Janghra N; Morgan JE; Sewry CA; Wilson FX; Davies KE; Muntoni F; Tinsley J
    PLoS One; 2016; 11(3):e0150818. PubMed ID: 26974331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological evaluation of rats carrying in-frame mutations in the dystrophin gene: a new model of Becker muscular dystrophy.
    Teramoto N; Sugihara H; Yamanouchi K; Nakamura K; Kimura K; Okano T; Shiga T; Shirakawa T; Matsuo M; Nagata T; Daimon M; Matsuwaki T; Nishihara M
    Dis Model Mech; 2020 Sep; 13(9):. PubMed ID: 32859695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of dystrophin-associated proteins in Becker/Duchenne muscular dystrophy with huge in-frame deletions in the NH2-terminal and rod domains of dystrophin.
    Matsumura K; Burghes AH; Mora M; Tomé FM; Morandi L; Cornello F; Leturcq F; Jeanpierre M; Kaplan JC; Reinert P
    J Clin Invest; 1994 Jan; 93(1):99-105. PubMed ID: 8282827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20.
    Mata López S; Hammond JJ; Rigsby MB; Balog-Alvarez CJ; Kornegay JN; Nghiem PP
    Skelet Muscle; 2018 May; 8(1):16. PubMed ID: 29843823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping.
    Walmsley GL; Arechavala-Gomeza V; Fernandez-Fuente M; Burke MM; Nagel N; Holder A; Stanley R; Chandler K; Marks SL; Muntoni F; Shelton GD; Piercy RJ
    PLoS One; 2010 Jan; 5(1):e8647. PubMed ID: 20072625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intragenic deletions in the dystrophin gene in 211 Pakistani Duchenne muscular dystrophy patients.
    Hassan MJ; Mahmood S; Ali G; Bibi N; Waheed I; Rafiq MA; Ansar M; Ahmad W
    Pediatr Int; 2008 Apr; 50(2):162-6. PubMed ID: 18353051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes of clinical variability in Duchenne and Becker muscular dystrophies and implications for exon skipping therapies.
    Hoffman EP
    Acta Myol; 2020 Dec; 39(4):179-186. PubMed ID: 33458572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy.
    Winnard AV; Klein CJ; Coovert DD; Prior T; Papp A; Snyder P; Bulman DE; Ray PN; McAndrew P; King W
    Hum Mol Genet; 1993 Jun; 2(6):737-44. PubMed ID: 8353493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exon deletion patterns of the dystrophin gene in 82 Vietnamese Duchenne/Becker muscular dystrophy patients.
    Tran VK; Ta VT; Vu DC; Nguyen ST; Do HN; Ta MH; Tran TH; Matsuo M
    J Neurogenet; 2013 Dec; 27(4):170-5. PubMed ID: 24099565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Becker muscular dystrophy severity is linked to the structure of dystrophin.
    Nicolas A; Raguénès-Nicol C; Ben Yaou R; Ameziane-Le Hir S; Chéron A; Vié V; Claustres M; Leturcq F; Delalande O; Hubert JF; Tuffery-Giraud S; Giudice E; Le Rumeur E;
    Hum Mol Genet; 2015 Mar; 24(5):1267-79. PubMed ID: 25348330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.